SCHEMBL17101112

SCHEMBL17101112

NNC(=O)c1c(-c2ccccc2)nc2ccccn12

nearest known ligand 0.66

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.66
KDM4E B2RXH2 3/20 0.66
KMT2A Q03164 3/20 0.66
GAA P10253 2/20 0.66
CYP1A2 P05177 1/20 0.62
CYP2C9 P11712 1/20 0.62
CYP2C19 P33261 1/20 0.62
SMN1; SMN2 Q16637 1/20 0.62
NTRK1 P04629 2/20 0.58
HSD17B10 Q99714 2/20 0.53
PKM P14618 1/20 0.53
HPGD P15428 1/20 0.53
NPSR1 Q6W5P4 1/20 0.52
MAPT P10636 1/20 0.52
POLB P06746 1/20 0.52
NPC1 O15118 1/20 0.51
RAB9A P51151 1/20 0.51
MAPK1 P28482 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22615009 0.89 ALDH1A1 (0.60) ALDH1A1KDM4EKMT2AGAACYP1A2
SCHEMBL12294853 0.86 SMN1; SMN2 (0.60) ALDH1A1KDM4ECYP1A2CYP2C9CYP2C19
SCHEMBL16797994 0.84 CYP1A2 (0.63) ALDH1A1KDM4EKMT2ACYP1A2CYP2C9
SCHEMBL19723739 0.83 SMN1; SMN2 (0.57) ALDH1A1KDM4EKMT2AGAACYP1A2
SCHEMBL6409798 0.83 CYP1A2 (0.66) ALDH1A1KDM4EKMT2ACYP1A2CYP2C9
SCHEMBL19723542 0.81 RAB9A (0.56) ALDH1A1KDM4EKMT2AGAACYP1A2
SCHEMBL13312213 0.81 CYP1A2 (0.67) ALDH1A1KDM4EKMT2ACYP1A2CYP2C9
SCHEMBL27465082 0.80 CYP1A2 (0.70) ALDH1A1KDM4ECYP1A2CYP2C9CYP2C19
SCHEMBL11253412 0.79 CYP1A2 (0.65) ALDH1A1KDM4EKMT2ACYP1A2CYP2C9
SCHEMBL4343195 0.79 KDM4E (1.00) ALDH1A1KDM4EKMT2AGAASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3119778-A1 SUBSTITUTED IMIDAZO[1,2-A]PYRIDINECARBOXAMIDES AND THEIR USE Bayer Pharma Aktiengesellschaft (DE) 2017-01-25 EP disclosed
WO-2015140254-A1 SUBSTITUTED IMIDAZO[1,2-A]PYRIDINECARBOXAMIDES AND THEIR USE BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2015-09-24 WO disclosed